Rosemary Wyber

2.8k total citations · 1 hit paper
81 papers, 1.7k citations indexed

About

Rosemary Wyber is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Rosemary Wyber has authored 81 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Public Health, Environmental and Occupational Health, 31 papers in Infectious Diseases and 31 papers in Epidemiology. Recurrent topics in Rosemary Wyber's work include Streptococcal Infections and Treatments (58 papers), Infective Endocarditis Diagnosis and Management (29 papers) and Antimicrobial Resistance in Staphylococcus (17 papers). Rosemary Wyber is often cited by papers focused on Streptococcal Infections and Treatments (58 papers), Infective Endocarditis Diagnosis and Management (29 papers) and Antimicrobial Resistance in Staphylococcus (17 papers). Rosemary Wyber collaborates with scholars based in Australia, United States and South Africa. Rosemary Wyber's co-authors include Jonathan R. Carapetis, Bongani M. Mayosi, Liesl Zühlke, Andrea Beaton, Kathryn A. Taubert, Ganesan Karthikeyan, Bo Reményi, Andrew C. Steer, Craig Sable and Nigel Wilson and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Rosemary Wyber

70 papers receiving 1.6k citations

Hit Papers

Acute rheumatic fever and rheumatic heart disease 2016 2026 2019 2022 2016 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosemary Wyber Australia 18 1.2k 645 606 308 161 81 1.7k
Samantha Colquhoun Australia 19 1.0k 0.8× 726 1.1× 566 0.9× 414 1.3× 87 0.5× 47 1.5k
Andrea Beaton United States 25 2.4k 2.0× 1.6k 2.5× 1.2k 2.0× 1.0k 3.3× 316 2.0× 112 3.4k
Benson R. Kidenya Tanzania 22 274 0.2× 499 0.8× 554 0.9× 99 0.3× 96 0.6× 119 1.5k
Elaine R. Miller United States 23 322 0.3× 584 0.9× 609 1.0× 90 0.3× 60 0.4× 49 1.6k
Elizabeth Dufort United States 14 406 0.3× 675 1.0× 1.3k 2.2× 182 0.6× 207 1.3× 28 2.4k
Eleanor Ochodo South Africa 19 417 0.3× 440 0.7× 531 0.9× 70 0.2× 94 0.6× 66 1.8k
Sanjat Kanjilal United States 19 358 0.3× 414 0.6× 1.2k 1.9× 121 0.4× 197 1.2× 47 2.2k
Elizabeth Sheridan United Kingdom 20 368 0.3× 557 0.9× 354 0.6× 185 0.6× 128 0.8× 43 1.8k
Ian C. Michelow United States 22 460 0.4× 1.1k 1.7× 793 1.3× 34 0.1× 195 1.2× 59 2.5k
Ana del Rı́o Spain 27 566 0.5× 1.3k 2.1× 1.0k 1.7× 298 1.0× 125 0.8× 73 2.3k

Countries citing papers authored by Rosemary Wyber

Since Specialization
Citations

This map shows the geographic impact of Rosemary Wyber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Wyber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Wyber more than expected).

Fields of papers citing papers by Rosemary Wyber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary Wyber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Wyber. The network helps show where Rosemary Wyber may publish in the future.

Co-authorship network of co-authors of Rosemary Wyber

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary Wyber. A scholar is included among the top collaborators of Rosemary Wyber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary Wyber. Rosemary Wyber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wyber, Rosemary, et al.. (2025). The need for community-controlled tools to monitor health impacts of housing and living conditions in Australia. Frontiers in Public Health. 13. 1509550–1509550.
2.
Wyber, Rosemary, Glenn Pearson, & Laurens Manning. (2025). Shortages of benzathine benzylpenicillin G in Australia highlight the need for new sovereign manufacturing capability. The Medical Journal of Australia. 222(5). 223–225.
4.
Enkel, Stephanie, Jessica Daw, Emma Pearson, et al.. (2024). Systematic Review of Household Transmission of Strep A: A Potential Site for Prevention That Has Eluded Attention. The Journal of Infectious Diseases. 230(4). e798–e806. 2 indexed citations
6.
Wyber, Rosemary, et al.. (2024). Inaccuracy of cardiovascular disease calculators in Australian primary health care software. Australian Journal of General Practice. 53(10). 782–784.
7.
Cannon, Jeffrey, et al.. (2023). Getting to grips with invasive group A streptococcal infection surveillance in Australia: are we experiencing an epidemic?. The Medical Journal of Australia. 219(6). 242–245. 3 indexed citations
8.
Cannon, Jeffrey & Rosemary Wyber. (2023). Modalities of group A streptococcal prevention and treatment and their economic justification. npj Vaccines. 8(1). 59–59. 2 indexed citations
9.
Wyber, Rosemary, Vicki Wade, Glenn Pearson, et al.. (2022). Improving primary prevention of acute rheumatic fever in Australia: consensus primary care priorities identified through an eDelphi process. BMJ Open. 12(3). e056239–e056239. 4 indexed citations
10.
Page‐Sharp, Madhu, Dianne Sika‐Paotonu, Meru Sheel, et al.. (2020). Quality of benzathine penicillin G: A multinational cross‐sectional study. Pharmacology Research & Perspectives. 8(6). e00668–e00668. 11 indexed citations
11.
Katzenellenbogen, Judith, Daniela Bond‐Smith, Rebecca Seth, et al.. (2019). <p>The End Rheumatic Heart Disease in Australia Study of Epidemiology (ERASE) Project: data sources, case ascertainment and cohort profile</p>. Clinical Epidemiology. Volume 11. 997–1010. 32 indexed citations
12.
Bond‐Smith, Daniela, Karen Dempsey, Jeffrey Cannon, et al.. (2019). The End Rheumatic Heart Disease in Australia Study of Epidemiology (ERASE) Project: data sources, case ascertainment and cohort profile. SHILAP Revista de lepidopterología.
13.
Webster, Graham R., Jürgen B. Bulitta, Cornelia B. Landersdorfer, et al.. (2018). Lessons learned in the development of sustained release penicillin drug delivery systems for the prophylactic treatment of rheumatic heart disease (RHD). Drug Delivery and Translational Research. 8(3). 729–739. 12 indexed citations
14.
Watkins, David, Andrea Beaton, Jonathan R. Carapetis, et al.. (2018). Rheumatic Heart Disease Worldwide. Journal of the American College of Cardiology. 72(12). 1397–1416. 107 indexed citations
15.
Palafox, Benjamin, Ana Olga Mocumbi, Raman Kumar, et al.. (2017). The WHF Roadmap for Reducing CV Morbidity and Mortality Through Prevention and Control of RHD. Global Heart. 12(1). 47–47. 42 indexed citations
16.
Katzenellenbogen, Judith, Anna P. Ralph, Rosemary Wyber, & Jonathan R. Carapetis. (2017). Rheumatic heart disease: infectious disease origin, chronic care approach. BMC Health Services Research. 17(1). 793–793. 31 indexed citations
17.
Wyber, Rosemary, Ben J. Boyd, Samantha Colquhoun, et al.. (2016). Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever. Drug Delivery and Translational Research. 6(5). 572–578. 26 indexed citations
18.
19.
Wyber, Rosemary, et al.. (2012). Aspiration pneumonia and challenges following the Samoa Tsunami in 2009.. PubMed. 125(1348). 70–8. 3 indexed citations
20.
Wyber, Rosemary, et al.. (2007). Medical students at an IPPNW World Congress: a growing force. Medicine Conflict & Survival. 23(2). 132–136.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026